Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.
Saved in:
| Title: | Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer. |
|---|---|
| Authors: | Foekens JA (AUTHOR), Look MP (AUTHOR), Peters HA (AUTHOR), van Putten WL (AUTHOR), Portengen H (AUTHOR), Klijn JG (AUTHOR), Foekens, J A1 (AUTHOR), Look, M P (AUTHOR), Peters, H A (AUTHOR), van Putten, W L (AUTHOR), Portengen, H (AUTHOR), Klijn, J G (AUTHOR) |
| Source: | JNCI: Journal of the National Cancer Institute. 5/17/95, Vol. 87 Issue 10, p751-756. 6p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
